Crossmark

C-reactive protein–triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with H-type hypertension

Crossref DOI link: https://doi.org/10.1186/s12933-026-03318-6

Published Online: 2026-08-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Li

Wang, Lian

Yu, Xian

Yang, Qiuyue

Ming, Xian

Xiong, Hongbo

Li, Dongsheng

Yan, Xisheng https://orcid.org/0000-0001-9960-6173
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81871088)

Hubei Province Health Science and Technology Project (WJ2025M008)

Wuhan Natural Science Foundation Clinical Research Key Project of Municipal Medical Institutions (2026020301040140)
License Information

Text and Data Mining valid from 2026-08-09

Accepted Manuscript valid from 2026-08-09
More Information

Article History

Received: 2 June 2026

Accepted: 24 July 2026

First Online: 9 August 2026

Declarations

Ethics approval and consent to participate: This study protocol was approved by the Ethics Committee of the Wuhan Third Hospital (KY2026-025), the study complied with the Declaration of Helsinki, and written informed consent was obtained from all participants.

Consent for publication: Not applicable.

Competing interests: The authors declare that there are no competing interests.

Document is current

Any future updates will be listed below